Mechanisms of ketamine-induced immunosuppression

Acta Anaesthesiologica Taiwanica

Volumn 50, Issue 4, 2012, Pages 172-177

  Liu, Feng Lin ^a   Chen, Ta Liang ^b   Chen, Ruei Ming ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

immunity, innate; immunosuppression; ketamine; mitogen Activated protein kinases; signal transduction; toll like receptors

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; KETAMINE; L SELECTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RAF PROTEIN; RAS PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; BASOPHIL; CELL ADHESION; CELL MIGRATION; CELLS; CHEMOTAXIS; DENDRITIC CELL; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EOSINOPHIL; GENE EXPRESSION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LEUKOCYTE; LEUKOCYTE FUNCTION; MACROPHAGE; MAST CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OXIDATION; PHAGOCYTOSIS; REVIEW;

ANIMALS; CHEMOTAXIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1BETA; INTERLEUKIN-6; KETAMINE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873407745     PISSN: 18754597     EISSN: 1875452X     Source Type: Journal    
DOI: 10.1016/j.aat.2012.12.001     Document Type: Review

References (68)

1. H. Ashton, and M.D. Young Davies' textbook of adverse drug reactions 1998 Chapman Hall Medical Publications UK
2. R. Craven Ketamine Anaesthesia 62 2007 48 53
3. P.F. White, W.L. Way, and A.J. Trevor Ketamine: its pharmacology and therapeutic uses Anesthesiology 56 1982 119 136
4. M.T. Lotze, and K.J. Tracey High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nat Rev Immunol 5 2005 331 342
5. C. Janeway, P. Travers, M. Walport, and M. Shlomchik Immunobiology 5th ed. 2001 Garland Science New York, London
6. H.Z. Rofael, R.M. Turkall, and M.S. Abdel-Rahman Effect of ketamine on cocaine-induced immunotoxicity in rats Int J Toxicol 22 2003 343 358
7. J. Yang, W. Li, M. Duan, Z. Zhou, N. Lin, and Z. Wang Large dose ketamine inhibits lipopolysaccharide-induced acute lung injury in rats Inflamm Res 54 2005 133 137
8. J.W. Suliburk, and D.W. Mercer Ketamine attenuates early lipopolysaccharide-induced gastric dysfunction: role of stress-inducible phosphoproteins J Trauma 62 2007 316 319
9. R.B. Herberman, and J.R. Ortaldo Natural killer cells: their role in defenses against diseases Science 214 1981 24 30
10. R. Melamed, S. Bar-Yosef, G. Shakhar, K. Shakhar, and S. Ben-Eliyahu Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures Anesth Analg 97 2003 1331 1339
11. S. Estes, T. Dinh, and N. Garrett A brief report of basic science: the effects of preincisional low-dose ketamine on natural killer cell activity in male Fischer 344 rats after intra-Abdominal surgery Dimens Crit Care Nurs 28 2009 41 44
12. M.A. Weigand, H. Schmidt, Q. Zhao, K. Plaschke, E. Martin, and H.J. Bardenheuer Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro Anesth Analg 90 2000 206 212
13. K. Maekawa, S. Futami, M. Nishida, T. Terada, H. Inagawa, and S. Suzuki Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b J Trauma 44 1998 460 468
14. I.D. Welters, G. Hafer, A. Menzebach, J. Muhling, C. Neuhauser, and P. Browning Ketamine inhibits transcription factors activator protein 1 and nuclear factor-{kappa}B, interleukin-8 production, as well as CD11b and CD16 expression: studies in human leukocytes and leukocytic cell lines Anesth Analg 110 2010 934 941
15. T. Sakai, T. Ichiyama, C.W. Whitten, A.H. Giesecke, and J.M. Lipton Ketamine suppresses endotoxin-induced NF-nB expression Can J Anaesth 47 2001 1019 1024
16. Y. Chang, T.L. Chen, J.R. Sheu, and R.M. Chen Suppressive effects of ketamine on macrophage functions Toxicol Appl Pharmacol 204 2005 27 35
17. T.L. Chen, C.C. Chang, Y.L. Lin, Y.F. Ueng, and R.M. Chen Signal-transducing mechanisms of ketamine-caused inhibition of interleukin-1β gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells Toxicol Appl Pharmacol 240 2009 15 25
18. H.C. Chang, K.H. Lin, Y.T. Tai, J.T. Chen, and R.M. Chen Lipoteichoic acid-induced TNF-α and IL-6 gene expressions and oxidative stress production in macrophages are suppressed by ketamine through downregulating toll-like receptor 2-mediated activation of ERK1/2 and NFκB Shock 33 2010 485 492
19. L. Härter, L. Mica, R. Stocker, O. Trentz, and M. Keel Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis Shock 22 2004 403 409
20. M. Yu, D. Shao, J. Yang, S. Feng, and J. Xu Ketamine suppresses intestinal TLR4 expression and NF-κB activity in lipopolysaccharide- treated rats Croat Med J 47 2006 825 831
21. M. Yu, D. Shao, X. Feng, M. Duan, and J. Xu Effects of ketamine on pulmonary TLR4 expression and NF-κB activation during endotoxemia in rats Methods Find Exp Clin Pharmacol 29 2007 395 399
22. M. Yu, D. Shao, J. Liu, J. Zhu, Z. Zhang, and J. Xu Effects of ketamine on levels of cytokines, NF-κB and TLRs in rat intestine during CLP-induced sepsis Int Immunopharmacol 7 2007 1076 1082
23. M. Yu, D. Shao, R. Yang, X. Feng, S. Zhu, and J. Xu Effects of ketamine on pulmonary inflammatory responses and survival in rats exposed to polymicrobial sepsis J Pharm Pharm Sci 10 2007 434 442
24. N. Ni Choileain, and H.P. Redmond Cell response to surgery Arch Surg 141 2006 1132 1140
25. C.A. Dinarello Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock Chest 112 1991 321S 327S
26. B. Beilin, Y. Rusabrov, Y. Shapira, L. Roytblat, L. Greemberg, and I.Z. Yardeni Low-dose ketamine affects immune responses in humans during the early postoperative period Br J Anaesth 99 2007 522 527
27. E. Roussabrov, J.M. Davies, H. Bessler, L. Greemberg, L. Roytblat, and I. Yardeni Effect of ketamine on inflammatory and immune responses after short-duration surgery in obese patients Open Anesthesiol J 2 2008 40 45
28. H.W. Lu, G.N. He, H. Ma, and J.K. Wang Ketamine reduces inducible superoxide generation in human neutrophils in vitro by modulating the p38 mitogen-Activated protein kinase (MAPK)-mediated pathway Clin Exp Immunol 160 2010 450 456
29. J. Sun, X.D. Wang, and H. Liu Ketamine suppresses endotoxin-induced NF-kappaB activation and cytokines production in the intestine Acta Anaesthesiol Scand 48 2004 317 321
30. G.J. Wu, T.L. Chen, Y.F. Ueng, and R.M. Chen Ketamine inhibits tumor necrosis factor-Alpha and interleukin-6 gene expressions in lipopolysaccharide- stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation Toxicol Appl Pharmacol 228 2008 105 113
31. Y. Yu, Z. Zhou, J. Xu, Z. Liu, and Y. Wang Ketamine reduces NFkappaB activation and TNFalpha production in rat mononuclear cells induced by lipopolysaccharide in vitro Ann Clin Lab Sci 32 2002 292 298
32. T.M. Carlos, and J.M. Harlan Leukocyte-endothelial adhesion molecules Blood 84 1994 2068 2101
33. E.C. Butcher Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity Cell 67 1991 1033 1036
34. H. Schmidt, D. Ebeling, H. Bauer, A. Bach, H. Bohrer, and M.M. Gebhard Ketamine attenuates endotoxin-induced leukocyte adherence in rat mesenteric venules Crit Care Med 23 1995 2008 2014
35. R. Hofbauer, D. Moser, V. Hammerschmidt, S. Kapiotis, and M. Frass Ketamine significantly reduces the migration of leukocytes through endothelial cell monolayers Crit Care Med 26 1998 1545 1549
36. S. Zahler, B. Heindl, and B.F. Becker Ketamine does not inhibit inflammatory responses of cultured human endothelial cells but reduces chemotactic activation of neutrophils Acta Anaesthesiol Scand 43 1999 1011 1016
37. F. Morel, J. Doussiere, and P.V. Vignais The superoxide-generating oxidase of phagocytic cells: physiological, molecular and pathological aspects Eur J Biochem 201 1991 523 546
38. K. Sakamoto, F. Kuribayashi, M. Nakamura, and K. Takeshige Involvement of p38 MAP kinase in not only activation of the phagocyte NADPH oxidase induced by Formyl-methionyl-leucyl-phenylalanine but also determination of the extent of the activity J Biochem 140 2006 739 745
39. A. Aderem Role of toll-like receptors in inflammatory response in macrophages Crit Care Med 29 2001 S16 S18
40. M. Shimaoka, T. Iida, A. Ohara, N. Taenaka, T. Mashimo, and T. Honda Ketamine inhibits nitric oxide production in mouse activated macrophage-like cells Br J Anaesth 77 1996 238 242
41. L.L. Pearce, M.W. Epperly, J.S. Greenberger, B.R. Pitt, and J. Peterson Identification of respiratory complexes I and III as mitochondrial sites of damage following exposure to ionizing radiation and nitric oxide Nitric Oxide 5 2001 128 136
42. S.D. Wright, R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 249 1990 1431 1433
43. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2003 783 801
44. X. Wittebole, D. Castanares-Zapatero, and P.F. Laterre Toll-like receptor 4 modulation as a strategy to treat sepsis Mediat Inflamm 2010 2010 568396
45. H. Fan, O.M. Peck, G.E. Tempel, P.V. Halushka, and J.A. Cook Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation Shock 22 2004 57 62
46. M.H. Kogut, K.J. Genovese, and H. He Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1 Mol Immunol 44 2007 1729 1736
47. W. Kolch Coordinating ERK/MAPK signalling through scaffolds and inhibitors Nat Rev Mol Cell Biol 6 2005 827 837
48. B.N. Kholodenko Untangling the signalling wires Nat Cell Biol 9 2007 247 249
49. M.A. Dobrovolskaia, A.E. Medvedev, K.E. Thomas, N. Cuesta, V. Toshchakov, and T. Ren Induction of in vitro reprogramming by toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on Nfkappa B signaling pathway components J Immunol 170 2003 508 519
50. D.R. Siwak, S. Shishodia, B.B. Aggarwal, and R. Kurzrock Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-Activated/extracellular signal-regulated protein kinase pathway and the Akt pathway Cancer 104 2005 879 890
51. C.H. Wu, T.L. Chen, T.G. Chen, W.P. Ho, W.T. Chiu, and R.M. Chen Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide- Activated macrophages J Trauma 55 2003 540 545
52. M. Yoshioka, N. Fukuishi, S. Iriguchi, K. Ohsaki, H. Yamanobe, and A. Inukai Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through toll-like receptor 2 J Allergy Clin Immunol 120 2007 452 461
53. T.R. Vogel, V.Y. Dombrovskiy, J.L. Carson, A.M. Graham, and S.F. Lowry Postoperative sepsis in the United States Ann Surg 252 2010 1065 1071
54. J.L. Vincent, Y. Sakr, C.L. Sprung, V.M. Ranieri, K. Reinhart, and H. Gerlach Sepsis occurrence in acutely ill patients' investigators. Sepsis in European intensive care units: results of the SOAP study Crit Care Med 34 2006 344 353
55. R. Salomão, P.S. Martins, M.K. Brunialti, L. Fernandes Mda, L.S. Martos, and M.E. Mendes TLR signaling pathway in patients with sepsis Shock 30 2008 73 76
56. H. Tsujimoto, S. Ono, P.A. Efron, P.O. Scumpia, L.L. Moldawer, and H. Mochizuki Role of toll-like receptors in the development of sepsis Shock 29 2009 315 321
57. K. Miyake, Y. Yamashita, Y. Hitoshi, K. Takatsu, and M. Kimoto Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells J Exp Med 180 1994 1217 1224
58. L.R. Watkins, S.F. Mair, and L.E. Goehler Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses, and pathological pain states Pain 63 1995 289 302
59. B. Beilin, Y. Shavit, E. Trabekin, B. Mordashev, E. Mayburd, and A. Zeidel The effects of postoperative pain management on immune response to surgery Anesth Analg 97 2003 822 827
60. G. Zilberstein, R. Levy, M. Rachinsky, A. Fisher, L. Greemberg, and Y. Shapira Ketamine attenuates neutrophil activation after cardiopulmonary bypass Anesth Analg 95 2005 531 536
61. L. Roytblat, D. Talmor, M. Rachinsky, L. Greemberg, A. Pekar, and A. Appelbaum Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass Anesth Analg 87 1998 266 271
62. T. Takahashi, M. Kinoshita, S. Shono, Y. Habu, T. Ogura, and S. Seki The effect of ketamine anesthesia on the immune function of mice with postoperative septicemia Anesth Analg 111 2010 1051 1058
63. X.M. Song, J.G. Li, Y.L. Wang, Q. Zhou, Z.H. Du, and B.H. Jia Effects of ketamine on proinflammatory cytokines and nuclear factor kappa B in polymicrobial sepsis rats World J Gastroenterol 12 2006 7350 7354
64. D.P. Lankveld, S. Bull, P. Van Dijk, J. Fink-Gremmels, and L.J. Hellebrekers Ketamine inhibits LPS-induced tumor necrosis factor- and interleukin-6 in an equine macrophage cell line Vet Res 36 2005 257 262
65. R. Gurfinkel, D. Czeiger, A. Douvdevani, Y. Shapira, A.A. Artru, and Y. Sufaro Ketamine improves survival in burn injury followed by sepsis in rats Anesth Analg 103 2006 396 402
66. G. Shaked, D. Czeiger, O. Dukhno, I. Levy, A.A. Artru, and Y. Shapira Ketamine improves survival and suppresses IL-6 and TNF-Alpha production in a model of Gram-negative bacterial sepsis in rats Resuscitation 62 2004 237 242
67. T. Taniguchi, K. Shibata, and K. Yamamoto Ketamine inhibits endotoxin-induced shock in rats Anesthesiology 95 2001 928 932
68. Z. Huang, S.R. Wang, W. Su, and J.Y. Liu Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column Ther Apher Dial 14 2010 596 602